Ascendis Pharma A/S Company Profile
NASDAQ: ASNDHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 11:23 AM ET
Ascendis Pharma A/S at a glance
Ascendis Pharma A/S (NASDAQ: ASND) is a Biotechnology: Pharmaceutical Preparations company in the Health Care sector headquartered in Hellerup, Denmark. Ascendis Pharma A/S is led by Mr. Jan Moller Mikkelsen and employs about 1,189 people. The company's shares have traded publicly since 2015.
At a market capitalization of $14.89 billion, it is considered a large-cap company. Its SEC Central Index Key (CIK) is 0001612042, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Ascendis Pharma A/S do?
Ascendis Pharma A/S, operates as a biopharmaceutical company that focuses on developing TransCon-based therapies for unmet medical needs in Europe, the United States, and internationally. The company offers SKYTROFA for treating pediatric patients with growth hormone deficiency; and YORVIPATH, a once-daily subcutaneous injection for the treatment of adults with chronic hypoparathyroidism. It is also developing a pipeline of three independent endocrinology rare disease product candidates in clinical development, as well as focuses on advancing oncology therapeutic candidates. The company was incorporated in 2006 and is based in Hellerup, Denmark.
Business description based on the company's public filings.
Company information
- Legal name
- Ascendis Pharma A/S
- Ticker
- NASDAQ: ASND
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- CEO
- Mr. Jan Moller Mikkelsen
- Employees
- 1,189
- Headquarters
- Tuborg Boulevard 12, Hellerup, Denmark
- Phone
- 45 70 22 22 44
- Website
- ascendispharma.com
- IPO year
- 2015
- Market cap
- $14.89B
- SEC CIK
- 0001612042
Companies similar to Ascendis Pharma A/S
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| JAZZJazz Pharmaceuticals plc | 218.34 | -5.56% | $14.17B | vs ASND |
| SMMTSummit Therapeutics Inc. | 17.04 | -5.07% | $13.59B | vs ASND |
| BBIOBridgeBio Pharma Inc. | 64.89 | -2.42% | $12.69B | vs ASND |
| CORTCorcept Therapeutics Incorporated | 116.46 | -2.63% | $12.59B | vs ASND |
| ELANElanco Animal Health Incorporated | 22.25 | -0.49% | $11.11B | vs ASND |
| MDGLMadrigal Pharmaceuticals Inc. | 475.49 | -2.51% | $10.99B | vs ASND |
| BMRNBioMarin Pharmaceutical Inc. | 54.28 | -1.68% | $10.51B | vs ASND |
| VTRSViatris Inc. | 17.16 | -1.89% | $19.71B | vs ASND |